Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „lamivudine“
Suchtreffer
Begriffe & Kennungen
Delstrigo · 4.5 · Expected: doravirine Interaction not studied with doravirine or ombitasvir/paritaprevir/ doravirine/lamivudine
Eintrag öffnenDelstrigo · 4.5 · Expected: lisinopril Antiandrogens Interaction not studied with doravirine or doravirine/lamivudine/tenofovir
Eintrag öffnenDelstrigo · 4.5 · Expected: ↑ tenofovir Interaction not studied with Patients receiving doravirine or doravirine/lamivudine/teno
Eintrag öffnenDelstrigo · 4.5 · Lamivudine Lamivudine does not inhibit or induce CYP enzymes.
Eintrag öffnenDelstrigo · 4.5 · ledipasvir AUC 0.92 (0.80, 1.06) Patients receiving Cmax 0.91 (0.80, 1.02) doravirine/lamivudine/tenofovirdi l
Eintrag öffnenDelstrigo · 4.8 · Table 2: Tabulated summary of adverse reactions associated with doravirine/lamivudine/tenofovir disoproxil
Eintrag öffnenDelstrigo · 4.8 · The safety of doravirine/lamivudine/tenofovir disoproxil was evaluated in 45 HIV-1 infected virologically supp
Eintrag öffnenDescovy · 4.8 · In a study of virologically suppressed adult patients switching from abacavir/lamivudine to Descovy while main
Eintrag öffnenDescovy · 4.8 · In a study of virologically suppressed adult patients switching from abacavir/lamivudine to Descovy while main
Eintrag öffnenDovato · 4.5 · 10 Cytotoxics Cladribine/Lamivudine Interaction not studied. Concomitant use of Dovato with cladribine is not
Eintrag öffnenDovato · 4.5 · 9 Trimethoprim/sulfamethoxazole Lamivudine: No dosage adjustment necessary. (Co-trimoxazole)/Lamivudine AUC
Eintrag öffnenDovato · 4.5 · Although lamivudine is a substrate of BCRP and P-gp in vitro, given its high absolute bioavailability, (see se
Eintrag öffnenDovato · 4.5 · Effect of dolutegravir and lamivudine on the pharmacokinetics of other medicinal products
Eintrag öffnenDovato · 4.5 · Effect of other medicinal products on the pharmacokinetics of dolutegravir and lamivudine
Eintrag öffnenDovato · 4.5 · In vitro, lamivudine was an inhibitor of OCT1 and OCT2; the clinical consequences are not known.
Eintrag öffnenDovato · 4.5 · Interactions between dolutegravir, lamivudine and co-administered medical products are listed in Table 1 (incr
Eintrag öffnenDovato · 4.5 · Lamivudine is cleared renally. Active renal secretion of lamivudine in the urine is mediated through the OCT2
Eintrag öffnenDovato · 4.5 · No drug interaction studies have been conducted using Dovato. Dovato contains dolutegravir and lamivudine, the
Eintrag öffnenDovato · 4.8 · Based on limited available data with the dolutegravir single entity or lamivudine single entity used in combin
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Krka · 4.5 · 11 Lamivudine/Tenofovir disoproxil Lamivudine: Lamivudine and AUC: ↓ 3% (↓ 8% to ↑ 15) Emtricitabine/Tenofovir
Eintrag öffnen